Answers are grounded in this paper and cite their sources.
Longitudinal study investigates expression of markers in oral dysplasia, predicting malignancy implication.
BACKGROUND: This study explored the expression patterns of epithelial-mesenchymal transition markers E-cadherin and beta-catenin in mild and moderate oral epithelial dysplasia (OED) to determine whether their expression predicts malignant progression in oral tissue. METHODS: Formalin-fixed paraffin-embedded tissue specimens with mild or moderate dysplasia were retrieved from 87 patients. Immunohistochemistry was performed to compare E-cadherin and beta-catenin expression in tissue sections that progressed to severe dysplasia, carcinoma in situ, or squamous cell carcinoma (n = 29) with those that did not progress (n = 58). Expression patterns were observed in the basal, parabasal, lower spinous, and upper spinous epithelial layers. Expression was assessed in the cell membrane for E-cadherin and beta-catenin (low expression = absent/weak staining, high = moderate/strong) and in the cytoplasm and nucleus for beta-catenin (low = absence, high = presence). Logistic regression was used to predict progression based on the expression pattern. RESULTS: There were no significant differences in the progression and expression patterns of E-cadherin and beta-catenin (p > 0.05). CONCLUSION: This study found that the expression of E-cadherin and beta-catenin was not a predictor of early malignant progression, highlighting the importance of longitudinal studies in studying progression.
No takes yet. Share an insight, caveat, or question.
Yim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: